Targeting ROS1 with anaplastic lymphoma kinase inhibitors: A promising therapeutic strategy for a newly defined molecular subset of non-small-cell lung cancer

10.1097/JTO.0b013e31826baf83

Saved in:

Bibliographic Details
Main Authors:	Chin, L.P., Soo, R.A., Soong, R., Ou, S.-H.I.
Other Authors:	CANCER SCIENCE INSTITUTE OF SINGAPORE
Format:	Review
Published:	2014
Subjects:	Anaplastic lymphoma kinase inhibitors Crizotinib Non-small-cell lung cancer ROS1 Targeted therapy
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/115550
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-115550
record_format	dspace
spelling	sg-nus-scholar.10635-1155502023-10-26T10:03:13Z Targeting ROS1 with anaplastic lymphoma kinase inhibitors: A promising therapeutic strategy for a newly defined molecular subset of non-small-cell lung cancer Chin, L.P. Soo, R.A. Soong, R. Ou, S.-H.I. CANCER SCIENCE INSTITUTE OF SINGAPORE Anaplastic lymphoma kinase inhibitors Crizotinib Non-small-cell lung cancer ROS1 Targeted therapy 10.1097/JTO.0b013e31826baf83 Journal of Thoracic Oncology 7 11 1625-1630 2014-12-12T07:16:56Z 2014-12-12T07:16:56Z 2012-11 Review Chin, L.P., Soo, R.A., Soong, R., Ou, S.-H.I. (2012-11). Targeting ROS1 with anaplastic lymphoma kinase inhibitors: A promising therapeutic strategy for a newly defined molecular subset of non-small-cell lung cancer. Journal of Thoracic Oncology 7 (11) : 1625-1630. ScholarBank@NUS Repository. https://doi.org/10.1097/JTO.0b013e31826baf83 15560864 http://scholarbank.nus.edu.sg/handle/10635/115550 000310057000008 Scopus
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	Anaplastic lymphoma kinase inhibitors Crizotinib Non-small-cell lung cancer ROS1 Targeted therapy
spellingShingle	Anaplastic lymphoma kinase inhibitors Crizotinib Non-small-cell lung cancer ROS1 Targeted therapy Chin, L.P. Soo, R.A. Soong, R. Ou, S.-H.I. Targeting ROS1 with anaplastic lymphoma kinase inhibitors: A promising therapeutic strategy for a newly defined molecular subset of non-small-cell lung cancer
description	10.1097/JTO.0b013e31826baf83
author2	CANCER SCIENCE INSTITUTE OF SINGAPORE
author_facet	CANCER SCIENCE INSTITUTE OF SINGAPORE Chin, L.P. Soo, R.A. Soong, R. Ou, S.-H.I.
format	Review
author	Chin, L.P. Soo, R.A. Soong, R. Ou, S.-H.I.
author_sort	Chin, L.P.
title	Targeting ROS1 with anaplastic lymphoma kinase inhibitors: A promising therapeutic strategy for a newly defined molecular subset of non-small-cell lung cancer
title_short	Targeting ROS1 with anaplastic lymphoma kinase inhibitors: A promising therapeutic strategy for a newly defined molecular subset of non-small-cell lung cancer
title_full	Targeting ROS1 with anaplastic lymphoma kinase inhibitors: A promising therapeutic strategy for a newly defined molecular subset of non-small-cell lung cancer
title_fullStr	Targeting ROS1 with anaplastic lymphoma kinase inhibitors: A promising therapeutic strategy for a newly defined molecular subset of non-small-cell lung cancer
title_full_unstemmed	Targeting ROS1 with anaplastic lymphoma kinase inhibitors: A promising therapeutic strategy for a newly defined molecular subset of non-small-cell lung cancer
title_sort	targeting ros1 with anaplastic lymphoma kinase inhibitors: a promising therapeutic strategy for a newly defined molecular subset of non-small-cell lung cancer
publishDate	2014
url	http://scholarbank.nus.edu.sg/handle/10635/115550
_version_	1781789400441552896

Targeting ROS1 with anaplastic lymphoma kinase inhibitors: A promising therapeutic strategy for a newly defined molecular subset of non-small-cell lung cancer

Similar Items